Preventive Use of Extended Half-Life Therapies Provides Enhanced Benefit for Hemophilia A Patients
According to a story from BioSpace, a recent study revealed that hemophilia A patients were less likely to experience bleeds when they used new, extended half-life therapies on a preventive…